Novel lipid emulsion for total parenteral nutrition based on 18-carbon n-3 fatty acids elicits a superior immunometabolic phenotype in a murine model compared with standard lipid emulsions.
We endeavor to develop a novel lipid emulsion for total parenteral nutrition use with superior immunometabolic actions compared with standard lipid emulsions.